In a recent article at ClinPage, they disclose that Bio-Imaging Technologies and Phoenix Data Systems will be merging to form BioClinic. This will be a new solution to track and manage clinical data.
Mark Weinstein, president and CEO of Bioclinica had this to say about the combined divisions. “The speed and accuracy of this combination helps to mend the current broken clinical trial process. We look forward to extending our imaging core lab leadership with comprehensive EDC services, and helping life science companies to manage their clinical trials with greater efficiency, quality and improved data visibility.”
Read the full story here.
Search This Blog
Blog Archive
-
▼
2009
(141)
-
▼
May
(15)
- As Sponsors increasingly look to CROs to provide e...
- Shifting Clinical Trial Environment
- Centralized patient recruitment
- Making the Business Case for Improving your Compar...
- Recession, stimulus bill open new doors for CROs
- Top Five States for Biotech Innovation
- ASKA Partners with International CROs
- Encorium looking for a buyer
- Phase III Clinical Trials
- Bio-Imiging Technologies and Phoenix Data Systems ...
- A Look at the 18th Annual Partnerships with CROs
- CASE STUDY: How Do Mergers, Acquisitions and Licen...
- Leveraging Relationship Structures to Optimize Spo...
- Outsourcing Clinical Trials in Emerging Regions: I...
- How to Make Change Part of Your Competitive Advantage
-
▼
May
(15)
No comments:
Post a Comment